ArticleFuture oncology (London, England)Published
Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Future oncology (London, England)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Ipilimumab; Nivolumab; Adverse Events; First-line Treatment; Advanced Nsclc; Immuno-oncology Regimens
- PubMed ID
- 38240151
- Open access
- Yes, open
- Added to directory
- Source checked